Treatment as Prevention Awareness Campaign
AIDS Resource is launching the Treatment as Prevention Awareness Campaign to help destigmatize HIV. The goal of this regional public awareness campaign is to educate communities about the effectiveness of HIV medications in preventing the acquisition and transmission of HIV.
Multiple Prevention Strategies
The most recognized prevention strategies are sex education programs, condoms and lubrication, regular HIV testing, and sexually transmitted infections (STI) testing and treatment. Learn more about our prevention and education programs.
There have been tremendous advances in the field of HIV. Scientific evidence shows that using HIV medication—antiretroviral therapy (ART)—can reduce the risk of acquiring and transmitting HIV. Prevention strategies using ART include undetectable equals untransmittable, PrEP, and PEP.
Undetectable Equals Untransmittable (U=U)
The amount of HIV present in the blood is the viral load. Taking antiretroviral therapy (ART) as prescribed can reduce the viral load in individuals living with HIV. An undetected viral load occurs when the viral load is so low that it does not show up in a standard viral load test. Clinical evidence has shown that when viral load levels are undetectable, then HIV cannot be transmitted through sex. Maintaining an undetectable viral load is one of the goals of ART.
Therefore, people living with HIV who take ART as prescribed and maintain an undetectable viral load have effectively no risk of sexually transmitting HIV. Not only do undetectable levels prevent HIV transmission, but it also allows individuals living with HIV to live longer, healthier lives. Click here to learn more about U=U.
Celebrity U=U Messages
Pre-exposure prophylaxis (PrEP) is an antiretroviral drug that HIV-negative individuals take daily to reduce their risk of getting HIV. PrEP is highly effective when taken as prescribed, however, it is much less effective if not taken consistently. Although PrEP protects against HIV, it does not provide protection against sexually transmitted infections (STI). Click here to learn more about PrEP.
Post-exposure prophylaxis (PEP) is an antiretroviral drug that HIV-negative individuals take for 28 days to lower the risk of getting HIV after a potential exposure (e.g., sexual assault, condomless sex, or needle sharing with someone who may have HIV). It must be started within 72 hours of the potential exposure, but it is best to start it as soon as possible after the potential exposure. PEP is used in emergency situations and is not meant for regular use.